Knock-Out Finder
Your selection:
23 Results
| MG06K7 |  | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 217.145 | 217.145 | 4.747 | 18.669% | - | Morgan Stanley | |
| MG2XFZ | | Alnylam Pharmaceuticals Inc./Faktor/Long [6]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 226.192 | 226.192 | 5.835 | 15.281% | - | Morgan Stanley | |
| MG6A5H | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 142.895 | 168.580 | 2.130 | 36.859% | - | Morgan Stanley | |
| MG6WDN | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 162.686 | 191.930 | 2.539 | 28.113% | - | Morgan Stanley | |
| MG6X19 | | Alnylam Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 203.573 | 203.573 | 3.775 | 23.753% | - | Morgan Stanley | |
| MG6X1A | | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 217.145 | 217.145 | 4.900 | 18.669% | - | Morgan Stanley | |
| MG6X76 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 179.971 | 179.971 | 3.009 | 32.593% | - | Morgan Stanley | |
| MG6X78 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 203.967 | 203.967 | 3.859 | 23.605% | - | Morgan Stanley | |
| MG783L | | Alnylam Pharmaceuticals Inc./Faktor/Long [3]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 180.954 | 180.954 | 2.876 | 32.224% | - | Morgan Stanley | |
| MJ6XU3 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 194.520 | 229.490 | 3.468 | 14.045% | - | Morgan Stanley | |
| MK17QY | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 152.962 | 180.460 | 2.325 | 32.409% | - | Morgan Stanley | |
| MK5DGN | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 244.792 | 244.792 | - | 8.314% | - | Morgan Stanley | |
| MK6NK1 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 232.523 | 232.523 | 6.033 | 12.910% | - | Morgan Stanley | |
| MK95AW | | Alnylam Pharmaceuticals Inc./Faktor/Short [2]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 407.045 | 407.045 | 2.104 | 52.457% | - | Morgan Stanley | |
| MK95AX | | Alnylam Pharmaceuticals Inc./Faktor/Short [4]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 339.204 | 339.204 | 4.326 | 27.047% | - | Morgan Stanley | |
| MM1MQQ | | Alnylam Pharmaceuticals Inc./Faktor/Short [5]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 325.636 | 325.636 | 5.503 | 21.965% | - | Morgan Stanley | |
| MM1MV5 | | Alnylam Pharmaceuticals Inc./Faktor/Long [2]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 135.715 | 135.715 | 1.955 | 49.168% | - | Morgan Stanley | |
| MM20JL | | Alnylam Pharmaceuticals Inc./Faktor/Short [3]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 361.817 | 361.817 | 3.197 | 35.517% | - | Morgan Stanley | |
| MN11W8 | | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 398.180 | 398.180 | 2.007 | 49.137% | - | Morgan Stanley | |
| MN9KUT | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 215.228 | 253.920 | 4.712 | 4.895% | - | Morgan Stanley | |
| MR1XNL | | Alnylam Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 203.573 | 203.573 | - | 23.753% | - | Morgan Stanley | |
| MR426K | | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 217.145 | 217.145 | - | 18.669% | - | Morgan Stanley | |
| MR4DLF | | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 300.000 | 300.000 | - | 12.364% | - | Morgan Stanley |